Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ricky W Johnstone

Showing results (41-50 of 188) with videos related to

Pageof 19
Sort By:
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
Overview of Histone Deacetylase Inhibitors in Haematological MalignanciesMark J Bishton, Ricky W Johnstone, Michael Dickinson, et al.
Leukemia|July 14, 2020
Distinct and overlapping mechanisms of resistance to azacytidine and guadecitabine in acute myeloid leukemiaEmily Gruber, Rheana L Franich, Jake Shortt, et al.
Cell Death & Disease|April 20, 2018
Down-regulation of a pro-apoptotic pathway regulated by PCAF/ADA3 in early stage gastric cancerDaniella Brasacchio, Rita A Busuttil, Tahereh Noori, et al.
Thrombosis Research|May 7, 2013
Histone deacetylase inhibitors reduce glycoprotein VI expression and platelet responses to collagen related peptideMark J Bishton, Elizabeth E Gardiner, Simon J Harrison, et al.
British Journal of Haematology|December 11, 2002
Histone deacetylase inhibitors potently repress CXCR4 chemokine receptor expression and function in acute lymphoblastic leukaemiaRoman Crazzolara, Karin Jöhrer, Ricky W Johnstone, et al.
Nature Reviews. Cancer|October 22, 2021
Targeting transcription cycles in cancerStephin J Vervoort, Jennifer R Devlin, Nicholas Kwiatkowski, et al.
International Journal of Cancer|April 30, 2002
Suberoylanilide hydroxamic acid (SAHA) overcomes multidrug resistance and induces cell death in P-glycoprotein-expressing cellsAstrid A Ruefli, David Bernhard, Kellie M Tainton, et al.
Haematologica|December 30, 2020
Whole genome CRISPR screening identifies TOP2B as a potential target for IMiD sensitization in multiple myelomaMatteo Costacurta, Stephin J Vervoort, Simon J Hogg, et al.
Immunity|February 28, 2012
Constitutive type I interferon modulates homeostatic balance through tonic signalingDaniel J Gough, Nicole L Messina, Christopher J P Clarke, et al.
Clinical Epigenetics|November 19, 2020
Correction to: Combining the differentiating effect of panobinostat with the apoptotic effect of arsenic trioxide leads to significant survival benefit in a model of t(8;21) acute myeloid leukemiaJessica M Salmon, Michael Bots, Eva Vidacs, et al.
Pageof 19

Showing results (41-50 of 188) with videos related to

Sort By:
Pageof 19
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
Overview of Histone Deacetylase Inhibitors in Haematological MalignanciesMark J Bishton, Ricky W Johnstone, Michael Dickinson, et al.
Leukemia|July 14, 2020
Distinct and overlapping mechanisms of resistance to azacytidine and guadecitabine in acute myeloid leukemiaEmily Gruber, Rheana L Franich, Jake Shortt, et al.
Cell Death & Disease|April 20, 2018
Down-regulation of a pro-apoptotic pathway regulated by PCAF/ADA3 in early stage gastric cancerDaniella Brasacchio, Rita A Busuttil, Tahereh Noori, et al.
Thrombosis Research|May 7, 2013
Histone deacetylase inhibitors reduce glycoprotein VI expression and platelet responses to collagen related peptideMark J Bishton, Elizabeth E Gardiner, Simon J Harrison, et al.
British Journal of Haematology|December 11, 2002
Histone deacetylase inhibitors potently repress CXCR4 chemokine receptor expression and function in acute lymphoblastic leukaemiaRoman Crazzolara, Karin Jöhrer, Ricky W Johnstone, et al.
Nature Reviews. Cancer|October 22, 2021
Targeting transcription cycles in cancerStephin J Vervoort, Jennifer R Devlin, Nicholas Kwiatkowski, et al.
International Journal of Cancer|April 30, 2002
Suberoylanilide hydroxamic acid (SAHA) overcomes multidrug resistance and induces cell death in P-glycoprotein-expressing cellsAstrid A Ruefli, David Bernhard, Kellie M Tainton, et al.
Haematologica|December 30, 2020
Whole genome CRISPR screening identifies TOP2B as a potential target for IMiD sensitization in multiple myelomaMatteo Costacurta, Stephin J Vervoort, Simon J Hogg, et al.
Immunity|February 28, 2012
Constitutive type I interferon modulates homeostatic balance through tonic signalingDaniel J Gough, Nicole L Messina, Christopher J P Clarke, et al.
Clinical Epigenetics|November 19, 2020
Correction to: Combining the differentiating effect of panobinostat with the apoptotic effect of arsenic trioxide leads to significant survival benefit in a model of t(8;21) acute myeloid leukemiaJessica M Salmon, Michael Bots, Eva Vidacs, et al.
Pageof 19